RankAlpha logo
Back to Rankings

PLUR

PluriD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
PLUR vs peer average
48/100
PLUR vs. peer average (D vs. D)
Grade spread
C 3 · D 3 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

NCEL is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $17.43M

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerNCELNewcelX
PLUR
Pluri
NCEL
NewcelX
Grade
D
D
Momentum
44
18
Value
41
46
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs NCEL

PLUR / NCEL
Grade Position
In line
PLUR vs. peer average (D vs. D)
48/100
Momentum
44
PLUR
Value
41
NCEL
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PLUR
1
NCEL
NewcelX Ltd Common
D
40/100
Even
2
LEXX
Lexaria Bioscience Corp Common
D
40/100
Even
3
KALA
KALA BIO Inc Common
D
40/100
Even
4
LPCN
Lipocine Inc Common
C
60/100
-1
5
PTN
Palatin Technologies Inc Common
F
20/100
+1
NCEL is the first peer returned for this comparison set.